Association between Psoriasis severity and steatosis measured by LIVERFASt easlfibronostg on June 29, 2026 Category: Publications Tag: Identification, LIVERFASt, MASLD, Steatosis Post navigation Previous: Previous post: Comparison of prevalence of advanced fibrosis using LiverSTAT or FIB-4 combined with LSM/VCTE in a prospective chronic liver disease cohort (Mongolia)Next: Next post: Combination of LF and LSM using Fibroscan outperforms FIB-4 and LSM in patients with T2D
